GeneDx Holdings Corp reports results for the quarter ended in March - Earnings Summary

GeneDx Holdings

10/05/2023 12:26

* GeneDx Holdings Corp  WGS.OQ  reported a quarterly
adjusted loss
of $2.44​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss of
$2.14 per share.
    * Revenue fell 20% to $43.14 million from a year ago;
analysts
expected $38.01 million. 
    * GeneDx Holdings Corp's reported EPS for the quarter was a
loss
of $3.04​.
    * The mean earnings estimate of analysts had risen by
about 37.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * GeneDx Holdings Corp shares had fallen by 30.7% this
quarter and
lost 4.1% so far this year.
    * The company reported a quarterly loss of $60.99 million.
    * Wall Street's median 12-month price target for GeneDx
Holdings
Corp is $37.13 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 11:26 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -2.14          -2.44          Missed
 Dec. 31 2022      -5.28          -8.25          Missed
 Sep. 30 2022      -7.01          -6.60          Beat
 Jun. 30 2022      -6.93          -8.25          Missed